您的位置:易推广 > 生物试剂/抗体/细胞 > 生物制剂 > 克隆系统 > 上海凯博生物科技有限公司(武汉分公司) > 产品展示 > 抗体 > 国产抗体 > phospho-DOK1(Tyr362)磷酸化D酪氨酸激酶衰减蛋白1抗体

产品展示

phospho-DOK1(Tyr362)磷酸化D酪氨酸激酶衰减蛋白1抗体

点击次数:234发布时间:2012/12/5 13:59:34

phospho-DOK1(Tyr362)磷酸化D酪氨酸激酶衰减蛋白1抗体

更新日期:2024/9/5 14:43:01

所 在 地:中国大陆

产品型号:BY-5289R

简单介绍:本公司经销phospho-DOK1(Tyr362),磷酸化D酪氨酸激酶衰减蛋白1抗体,克隆类型为polyclonal,宿主来源是Rabbit,phospho-DOK1(Tyr362)磷酸化D酪氨酸激酶衰减蛋白1抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

优质供应

详细内容

本公司经销phospho-DOK1(Tyr362),磷酸化D酪氨酸激酶衰减蛋白1抗体,克隆类型为polyclonal,宿主来源是Rabbit,phospho-DOK1(Tyr362)磷酸化D酪氨酸激酶衰减蛋白1抗体可应用于WB、elisa、IP、IF、IHC等实验,欢迎垂询订购!

货号:BY-5289R
英文名称:Anti-phospho-DOK1(Tyr362)
中文名称:磷酸化D酪氨酸激酶衰减蛋白1抗体
其他名称:名DOK1; downstream of tyrosine kinase 1; docking protein 1; Docking protein 1; docking protein 1 62kD; DOK 1; P62DOK; pp62; DOK 1; DOK-1; p62DOK1.
抗体来源:Rabbit
克隆类型:polyclonal
蛋白分子量:predicted molecular weight: 62kDa
纯化方法:affinity purified by Protein A
交叉反应:hu, mo, rat, pig, cow, dog
产品介绍:Docking protein 1 is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210(bcr/abl), a chimeric protein whose presence is associated with CML. Docking protein 1 contains a putative pleckstrin homology domain at the amino terminus and ten PXXP SH3 recognition motifs. Docking protein 2 binds p120 (RasGAP) from CML cells. It has been postulated to play a role in mitogenic signaling.Subunit : Interacts with ABL1 (By similarity). Interacts with RasGAP and INPP5D/SHIP1. Interacts directly with phosphorylated ITGB3.Subcellular Location : Isoform 1: Cytoplasm. Isoform 3: Cytoplasm, perinuclear region.Tissue Specificity : Expressed in pancreas, heart, leukocyte and spleen. Expressed in both resting and activated peripheral blood T-cells.Similarity : Belongs to the DOK family. Type A subfamily.Contains 1 IRS-type PTB domain.Contains 1 PH domain.

联系我们

联系人:王羽

点击查看联系方式

企业档案

  • 会员类型:免费会员
  • 工商认证: 【未认证】
  • 最后认证时间:
  • 法人:
  • 注册号:****
  • 企业类型:生产商
  • 注册资金:人民币**万

script>
在线咨询

提交